Viewing Study NCT03608761


Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2026-01-10 @ 4:29 PM
Study NCT ID: NCT03608761
Status: COMPLETED
Last Update Posted: 2018-12-04
First Post: 2018-07-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison Between Rebamipide 2% Versus Autologous Serum
Sponsor: Hospital Nacional Profesor Alejandro Posadas
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-02-06
Start Date Type: ACTUAL
Primary Completion Date: 2017-10-09
Primary Completion Date Type: ACTUAL
Completion Date: 2018-07-09
Completion Date Type: ACTUAL
First Submit Date: 2018-07-09
First Submit QC Date: None
Study First Post Date: 2018-08-01
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-12-02
Last Update Post Date: 2018-12-04
Last Update Post Date Type: ACTUAL